Class-Action Lawsuit Challenges Pfizer's DTC Ad Claim of Lipitor's Effectiveness in Reducing Cholesterol Levels, Wall Street Journal Reports

Main Category: Cholesterol
Article Date: 29 Sep 2005 - 23:00 PST

email icon email to a friend   printer icon printer friendly   write icon opinions  


Current Article Ratings:

Patient / Public:4 and a half stars

4.41 (34 votes)

Healthcare Prof:5 stars

4.8 (5 votes)

Article Opinions: 2 posts

A lawsuit filed by consumer advocates in U.S. District Court in Boston alleges that Pfizer marketed the cholesterol drug Lipitor to women and the elderly without proof that Lipitor reduces the risk of heart disease in those groups, the Wall Street Journal reports. The plaintiffs -- which include advocacy group Health Care for All and health plans for a New Jersey Teamsters union local, a Brooklyn woman and an elderly Massachusetts man -- allege that Pfizer's sales and marketing campaigns focused on cholesterol reduction and suggested that the medication protects against heart disease. However, there is a lack of proof that Lipitor's effect on cholesterol protects against heart attacks and strokes in women and the elderly with no prior history of the diseases, according to the suit. It also alleges that the company's marketing campaigns violated state consumer protection laws against unfair and deceptive trade practices. The plaintiffs state that although studies show the medication is helpful in lowering cholesterol in men with a high risk of cardiovascular disease, no such proof exists for women or the elderly. The groups are seeking compensation for women and the elderly who paid for Lipitor and insurance companies that paid for the medication on their behalf. A Pfizer spokesperson declined to comment on the suit, saying that the company had not been served, the Journal reports (Hensley, Wall Street Journal, 9/29).

"Reprinted with permission from http://www.kaisernetwork.org. You can view the entire Kaiser Daily Health Policy Report, search the archives, or sign up for email delivery at http://www.kaisernetwork.org/dailyreports/healthpolicy. The Kaiser Daily Health Policy Report is published for kaisernetwork.org, a free service of The Henry J. Kaiser Family Foundation . © 2005 Advisory Board Company and Kaiser Family Foundation. All rights reserved.

Article adapted by Medical News Today from original press release.
Visit our cholesterol section for the latest news on this subject.
There are no references listed for this article.
Please use one of the following formats to cite this article in your essay, paper or report:

MLA
Paul Lachynsky. "Class-Action Lawsuit Challenges Pfizer's DTC Ad Claim of Lipitor's Effectiveness in Reducing Cholesterol Levels, Wall Street Journal Reports." Medical News Today. MediLexicon, Intl., 29 Sep. 2005. Web.
9 Feb. 2012. <http://www.medicalnewstoday.com/releases/31380.php>

APA
Paul Lachynsky. (2005, September 29). "Class-Action Lawsuit Challenges Pfizer's DTC Ad Claim of Lipitor's Effectiveness in Reducing Cholesterol Levels, Wall Street Journal Reports." Medical News Today. Retrieved from
http://www.medicalnewstoday.com/releases/31380.php.

Please note: If no author information is provided, the source is cited instead.




Cholesterol

What Is Cholesterol?

Cholesterol is a fat (lipid) which is produced by the liver and is crucial for normal body functioning. Cholesterol exists in the outer layer of every cell in our body and has many functions. Read more...

Most Popular Articles



Follow Our Cholesterol News On Twitter

Follow Us On Twitter
Get the latest news for this category delivered straight to your Twitter account. Simply visit our Cholesterol Twitter account and select the 'follow' option.



View list of all 'What Is...' articles »